CGAS and cancer: There was substantial increase in interferon response genes, which along with TMEM173 mRNA expression, suggested PARP inhibition activated the cGAS–cGAMP–STING pathway in HR-deficient cancers (Fig. 5d and Supplementary Fig. 4).